Tests:SARS-Cov-2 NAAT (POCT): Difference between revisions
Tests:SARS-Cov-2 NAAT (POCT)
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE: SARS-CoV-2 NAAT (POCT)}} | \{{DISPLAYTITLE: SARS-CoV-2 NAAT (POCT)}} | ||
[[Category:Tests]] | [[Category:Tests]] | ||
[[Category:POCT]] | [[Category:POCT]] | ||
| Line 16: | Line 16: | ||
|- | |- | ||
|'''Availability''' | |'''Availability''' | ||
| | |Only available at Taranaki Base ED and Hawera ED | ||
|- | |- | ||
|'''Turnaround Time''' | |'''Turnaround Time''' | ||
| | |Once Patients sample has been placed on the analyser, results can be obtained no longer than 15 minutes | ||
|- | |- | ||
|'''Stability – Add test''' | |'''Stability – Add test''' | ||
| | |Dry swab sample must be processed ASAP | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Specimen Requirements == | == '''Specimen Requirements''' == | ||
|- | |- | ||
|Specimen | |'''Specimen''' | ||
| | |Nasal or Nasopharyngeal swab | ||
|- | |- | ||
|Preferred | |'''Preferred''' | ||
|Nasopharyngeal swab | |Nasopharyngeal swab | ||
|- | |- | ||
|Acceptable | |'''Acceptable''' | ||
| | |Only sample taken with <u>dry swab</u> included in the ID NOW test kits. | ||
|- | |- | ||
|Unacceptable | |'''Unacceptable''' | ||
| | |Any other swabs not as part of the testing kit | ||
|- | |- | ||
|Specimen Transportation | |'''Specimen Transportation''' | ||
|ASAP to | |Room temperature/ambient and ASAP to the analyser for processing | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == '''Test Information''' == | ||
|- | |- | ||
| | |'''Test Method''' | ||
| | |ID NOW - COVID 19 (ABBOTT) | ||
Real-time isothermal Nucleic Acid Amplification Test (NAAT) | |||
|- | |- | ||
| | |'''Units of Measurement''' | ||
| | |Qualitative | ||
|- | |- | ||
| | |'''Reference Intervals''' | ||
| | |Results, reported as SARS-CoV-2 POCT NAAT either as - DETECTED or NOT Detected. | ||
No Ct values are available for this test | |||
|- | |- | ||
| | |'''uncertainty of Measurement''' | ||
| | |N/A | ||
|- | |- | ||
| | |'''Additional Informationm''' | ||
|To minimise inhibition in the | |To minimise inhibition in the testing, please ensure the patients' blow their nose prior to taking either Nasal or Nasopharyngeal swab. | ||
Specimens that fail for technical reasons can be tested by another platform in the Laboratory. A repeat sample is to be requested using a QUAD swab (VTM swab) | |||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Comments == | == '''Comments''' == | ||
|- | |- | ||
| colspan="2" | | | colspan="2" |Please note that a negative SARS-CoV-2 point-of-care test may not fully exclude COVID-19 infection. A second sample for repeat POC or laboratory PCR can be considered if there is a high clinical suspicion of infection. | ||
|} | |} | ||
{{DocMeta | {{DocMeta | ||